JENNIFER HERBIN: Open Payments
NPI 1962827576 · BASTROP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,820 in 110 payments from 20 companies in 2025. Trend: 2023 $33 · 2024 $493 · 2025 $1,820
Food & beverage: $1,735Education: $84
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $351 |
| ABBVIE INC. | 21 | $315 |
| Lilly USA, LLC | 13 | $183 |
| PFIZER INC. | 10 | $161 |
| GlaxoSmithKline, LLC. | 6 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $84 |
| TOLMAR, INC. | 4 | $75 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
Products named: VRAYLAR, Rybelsus, JARDIANCE, NURTEC ODT, Ozempic, TRELEGY ELLIPTA, CAPLYTA, JATENZO.
Industry payments across TX — which companies pay providers there.
